Location History:
- Tokyo, JP (1991)
- St. Petersburg, FL (US) (1994 - 1997)
Company Filing History:
4 out of 12 
1 out of 832,912 Years Active: 1991-1997
Title: Meihan Nonoyama: Innovator in Anti-HIV Protein Research
Introduction
Meihan Nonoyama is a notable inventor based in St. Petersburg, FL (US), recognized for his contributions to the field of biomedical research. He holds a total of five patents, focusing primarily on proteins with anti-HIV activity. His innovative approaches have the potential to significantly impact the treatment of HIV.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Protein having anti-HIV activity and method for obtaining it." This patent describes a method for culturing CD4-positive T cells, specifically a subclone of CEM cells designated 4084, to produce and secrete a protein with potent anti-HIV activity. The protein, which has a molecular weight of at least 30,000 daltons, is recovered from the culture medium after the cells are separated. Another significant patent is the "Process for obtaining cellular protein having anti-HIV activity," which outlines a similar method involving the culturing of CD4-positive T cells or myeloid cells. This process results in a protein with a molecular weight ranging from about 7,000 to about 12,000 daltons, as determined by gel filtration analysis.
Career Highlights
Throughout his career, Meihan Nonoyama has worked with various research institutions, including the Tampa Bay Research Institute. His work has been pivotal in advancing the understanding of proteins that can combat HIV, showcasing his dedication to innovative research in the biomedical field.
Collaborations
Meihan has collaborated with several professionals in his field, including Akiko Tanaka and Patrick K Lai. These collaborations have enriched his research and contributed to the development of his patented technologies.
Conclusion
Meihan Nonoyama's innovative work in the field of anti-HIV proteins exemplifies the impact of dedicated research on global health challenges. His patents and collaborations highlight the importance of scientific innovation in the fight against HIV.